Tekturna® (aliskiren) – Expanded indication and new formulation
November 14, 2017 – Noden Pharma announced the FDA approval of Tekturna (aliskiren), for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure.
Download PDF
